BlackRock, Inc. 13D and 13G filings for Cassava Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 1,545,375 3.200% | -1,492,040 (-49.12%) | Filing |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 3,037,415 7.200% | 472,887 (+18.44%) | Filing |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 2,564,528 6.100% | -196,450 (-7.12%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 2,760,978 6.900% | 790,209 (+40.10%) | Filing |
| 2021-02-05 5:01 pm Unchanged | 2020-12-31 | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 1,970,769 5.600% | 0 (Unchanged) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 1,970,769 5.600% | 1,767,649 (+870.25%) | Filing |